Sera Prognostics, Inc. Class A (SERA) Dividend History

Sera Prognostics, Inc. Class A (SERA) is a biotechnology company focused on developing maternal-fetal health diagnostics. The firm specializes in creating tests aimed at predicting the risk of preterm birth and other pregnancy complications, leveraging proteomic and biomarker analysis to improve maternal and neonatal outcomes.

2749 E. Parleys Way, Salt Lake City, UT, 84109
Phone: (801) 990-0520
Website: https://www.seraprognostics.com

Dividend History

Sera Prognostics, Inc. Class A currently does not pay dividends

Company News

Elevance Health (ELV) Rallies 11.8% YTD: More Room to Run?

Elevance Health's (ELV) performance benefits from new contract wins, a strong Carelon segment and recovering Medicaid business.

Zacks Investment Research

Featured Companies: BKD EHC ELV
Brookdale (BKD) Sees 31 Months of Y/Y Occupancy Growth Streak

Brookdale's (BKD) weighted average occupancy for the second quarter-to-date rises 160 bps year over year to 78%.

Zacks Investment Research

Featured Companies: AURA BKD HQY
Select Medical (SEM) Rises 42.4% YTD: More Growth Ahead?

Select Medical (SEM) will continue to gain from rising admissions within the Critical Illness Recovery Hospital and Rehabilitation Hospital segments.

Zacks Investment Research

Featured Companies: BKD HQY SEM
Will UnitedHealth (UNH) Dividend Hike Fail to Excite Investors?

UnitedHealth's (UNH) strong financial position supports its shareholder value boosting efforts.

Zacks Investment Research

Featured Companies: BKD HQY UNH
Cigna's (CI) Express Scripts Collaborates With CPESN USA

Cigna's (CI) Express Scripts collaborates with CPESN USA in a bid to enhance care delivery for hypertension and diabetes patients.

Zacks Investment Research

Featured Companies: BKD CI HQY

Dividend data last updated 06/07/2025 02:14:36 UTC